Author

Daniel Storey 1

1 Royal Liverpool and Broadgreen University Hospitals NHS Trust,Division of Gastroenterology and Hepatology,Liverpool,United Kingdom

BASELINE CALPROTECTIN DOES NOT PREDICT RESPONSE TO BIOLOGICAL THERAPY IN ULCERATIVE COLITIS

Daniel Storey, Thomas Skouras, Ashley Bond, Susanna Dodd, Sree Subramanian

EFFICACY AND SAFETY OF ELECTIVE SWITCHING OF INFLAMMATORY BOWEL DISEASE PATIENTS FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB: A MULTI-CENTRE COHORT STUDY

Wan Yi Teoh, Stephan Vazille, Solange Serna, Chris Probert, Keith Bodger, Philip Smith, Ajay M Verma, Daniel Storey, Belle Gregg, Lisa Critchley, June Stenson, Andrew Kneebone, Tracy Rimmer, Shamas Hussain, Sree Subramanian, Edmund Derbyshire, Paul Collins, Ashley Bond, Stevena Burke, Alan Steel, Martyn Dibb

EFFICACY OF SUBCUTANEOUS INFLIXIMAB IN PERIANAL CROHN’S DISEASE

Martyn Dibb, Alan Steel, Philip Smith, Paul Collins, Daniel Storey, Belle Gregg, Lisa Critchley, June Stenson, Ashley Bond, Sree Subramanian, Edmund Derbyshire, Chris S. J. Probert

ROLE OF BASELINE INFLAMMATORY MARKERS IN PREDICTING EARLY RESPONSE AND REMISSION TO VEDOLIZUMAB

Thomas Skouras, Chris S. J. Probert, Paul Collins, Ashley Bond, Gareth Fisher, Belle Gregg, Daniel Storey, Hayley Stanley, Sree Subramanian

SAFETY AND EFFICACY OF USTEKINUMAB FOR CROHN'S DISEASE (CD): THE CROSS PENNINE EXPERIENCE

Vivien Dolby, Tanya Clark, Veronica Hall, Suzanne Tattersall, Francesca Fairhurst, Catherine Kenneth, Rachael Walker, Karen Kemp, Simon Borg-Bartolo, Jimmy K. Limdi, Jo Taylor, Tristan Townsend, Sreedhar Subramaniam, Daniel Storey, Arash Assadsangabi, Catherine Stansfield, Paul Smith, Debra Byrne, Marco Vincenzo Lenti, C

Item 1 - 5 / 5
1